Southern Oncology Clinical Research Unit (SOCRU) is a dedicated Phase 1 private clinical research site in Adelaide, South Australia. Our team is committed to advancing cancer research and providing exceptional, evidence-based, patient-centred care. Led by a team of five experienced oncologists, SOCRU specialises in conducting clinical trials involving cytotoxic agents, targeted therapies, immunotherapy, and genetically modified organism therapies. The unit is renowned for successfully managing complex studies, particularly those involving high-reaction-risk products and extended PK collection timepoints.
With a proven track record in swift startup timelines, SOCRU excels in regulatory submissions and rapid trial initiation. The unit is also recognised for its strong recruitment rates, consistently enrolling eligible patients efficiently and effectively across a wide range of trials.
Our facilities include:
Day Infusion Suite
Overnight beds for prolonged admissions
24 hour patient monitoring
Out of hours include late and weekend PK sample collection and processing
Access to telemetry and 24 hour Cardiac Monitoring
Private Consulting Rooms
On-site radiology provider
Biosafety PC2 level laboratory access
Hospital Emergency Services Department on Call (MET calls)
Access to ICU beds, if required